Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-10-11 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | Plaintiff | Referred To | |
Patents | 8,349,840; 8,618,109; 9,839,637 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd.
Details for Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-09-21 | 575 | Order - -Memorandum and Order | opinions with respect to the patents-in-suit (U.S. Patent Nos. RE48,059, 8,349,840, 8,618,109, and 9,839,637…9,839,637; hereinafter, the “Brexpiprazole Patents”). (See D.I. 555 at 5) In their view, “a person of ordinary…b]efore the priority date of the Brexpiprazole Patents, Dr. Aubé was not a person of ordinary skill, … 11 October 2019 1:19-cv-01938-LPS Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |